About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGPhase 1NCT07044271

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The stud...

Lead sponsor: Eli Lilly and Company•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

CONTACT

1-317-615-4559 LillyTrials@Lilly.com

Physicians interested in becoming principal investigators please contact

CONTACT

clinical_inquiry_hub@lilly.com

Sponsors

Lead Sponsor

Eli Lilly and Company

Age

18 - 55 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy status as defined by the absence of evidence of any clinically significant active or chronic disease
•Body mass index (BMI): 18.0 to 30.0 kilograms per square meter (kg/m²), inclusive
•Participants assigned male at birth (AMAB) or assigned female at birth (AFAB) who are individuals not of childbearing potential (INOCBP).

Exclusion Criteria

•Females who are lactating or of childbearing potential
•Clinically significant history of any drug sensitivity, drug allergy, or food allergy
•Have used or plan to use medication within 14 days or 5 half-lives, whichever is longest, prior to admission, with the exception occasional acetaminophen at doses less than or equal to 2 g/day.

Related studies

RECRUITINGPhase 1

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function

NCT07269301 · Hepatic Impairment, Healthy

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

NCT05545306 · Obesity, Normal Physiology, and more

RECRUITINGPhase 1

A Trial to Assess Safety, Tolerability, and Pharmacokinetics of AN01 Inhalation Powder in Healthy Participants

NCT07554365 · Healthy Volunteer, Healthy Participants Study

Adipose Tissue Blood Flow in Aging Humans

NCT06096532 · Healthy, Aging

RECRUITINGPhase 1/2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 20, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE1

Enrollment120

Start dateJul 2025

Last updatedOct 20, 2025

Condition

Locations shown

ICON Early Phase Services

San Antonio, Texas

ICON

Salt Lake City, Utah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 20, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions